Richard Rosales1, Edwin Amirianfar2, Michael Appeadu2, David Gater2, Chane Price2. 1. Department of Physical Medicine and Rehabilitation at University of Miami/Jackson Memorial Hospital, Miami, FL, USA. richardar23@gmail.com. 2. Department of Physical Medicine and Rehabilitation at University of Miami/Jackson Memorial Hospital, Miami, FL, USA.
Abstract
INTRODUCTION: Neuropathic pain is a common complication of spinal cord injury (SCI), and is notoriously difficult to adequately treat. Gunshot wounds (GSW) near the spinal cord may cause intractable chronic pain through spinal/nerve root transection, or reactive tissue formation resulting in nerve root compression from retained bullet fragments (RBF). CASE PRESENTATION: This case report describes a 30-year-old man with a T12 AIS B incomplete spinal cord injury with paraplegia secondary to multiple GSW who presented with severe bilateral lower extremity dysesthesias and muscle spasms. Symptoms failed to improve with oral antispasmodic medications. After being diagnosed with Complex regional pain syndrome (CRPS) type I secondary to an SCI via GSW, he underwent a spinal cord stimulator (SCS) trial, which improved his symptoms by greater than 80%. DISCUSSION: Neuropathic pain refractory to conservative treatment may benefit from SCS. Effects of therapy go beyond gate-theory in SCI patients, and may benefit patients at the cellular and molecular level. Our case demonstrates the effectiveness of SCS treatment in a patient who developed CRPS type 1 after GSW resulting in SCI.
INTRODUCTION: Neuropathic pain is a common complication of spinal cord injury (SCI), and is notoriously difficult to adequately treat. Gunshot wounds (GSW) near the spinal cord may cause intractable chronic pain through spinal/nerve root transection, or reactive tissue formation resulting in nerve root compression from retained bullet fragments (RBF). CASE PRESENTATION: This case report describes a 30-year-old man with a T12 AIS B incomplete spinal cord injury with paraplegia secondary to multiple GSW who presented with severe bilateral lower extremity dysesthesias and muscle spasms. Symptoms failed to improve with oral antispasmodic medications. After being diagnosed with Complex regional pain syndrome (CRPS) type I secondary to an SCI via GSW, he underwent a spinal cord stimulator (SCS) trial, which improved his symptoms by greater than 80%. DISCUSSION: Neuropathic pain refractory to conservative treatment may benefit from SCS. Effects of therapy go beyond gate-theory in SCI patients, and may benefit patients at the cellular and molecular level. Our case demonstrates the effectiveness of SCS treatment in a patient who developed CRPS type 1 after GSW resulting in SCI.
Authors: Marissa L Dombovy-Johnson; Christine L Hunt; Melissa M Morrow; Tim J Lamer; Thomas P Pittelkow Journal: Pain Pract Date: 2020-02-10 Impact factor: 3.183
Authors: Jacob Caylor; Rajiv Reddy; Sopyda Yin; Christina Cui; Mingxiong Huang; Charles Huang; Rao Ramesh; Dewleen G Baker; Alan Simmons; Dmitri Souza; Samer Narouze; Ricardo Vallejo; Imanuel Lerman Journal: Bioelectron Med Date: 2019-06-28
Authors: S D Guy; S Mehta; A Casalino; I Côté; A Kras-Dupuis; D E Moulin; A G Parrent; P Potter; C Short; R Teasell; C L Bradbury; T N Bryce; B C Craven; N B Finnerup; D Harvey; S L Hitzig; B Lau; J W Middleton; C O'Connell; S Orenczuk; P J Siddall; A Townson; C Truchon; E Widerström-Noga; D Wolfe; E Loh Journal: Spinal Cord Date: 2016-08 Impact factor: 2.772
Authors: Pradip M Pattany; Robert P Yezierski; Eva G Widerström-Noga; Brian C Bowen; Alberto Martinez-Arizala; Bernardo R Garcia; Robert M Quencer Journal: AJNR Am J Neuroradiol Date: 2002 Jun-Jul Impact factor: 3.825